Pre-Operative PARPi and Irradiation (POPI) in Women With an Incomplete Response to Neo-Adjuvant Chemotherapy for Breast Cancer
Phase of Trial: Phase I
Latest Information Update: 27 Sep 2017
At a glance
- Drugs Veliparib (Primary)
- Indications Breast cancer
- Focus Adverse reactions
- 21 Sep 2017 Planned End Date changed from 1 Apr 2017 to 31 Dec 2018.
- 21 Sep 2017 Planned primary completion date changed from 1 Apr 2017 to 31 Dec 2017.
- 15 Aug 2016 Status changed from suspended to recruiting.